Format

Send to

Choose Destination
Clin Immunol. 2015 Aug;159(2):143-53. doi: 10.1016/j.clim.2015.05.013. Epub 2015 Jun 4.

The gut microbiota and Type 1 Diabetes.

Author information

1
Section of Endocrinology, Yale University School of Medicine, New Haven, CT, USA.
2
Institute of Molecular and Experimental Medicine, Cardiff University School of Medicine, Cardiff, UK.
3
Section of Endocrinology, Yale University School of Medicine, New Haven, CT, USA. Electronic address: li.wen@yale.edu.

Abstract

Type 1 Diabetes (T1D) is a multifactorial, immune-mediated disease, which is characterized by the progressive destruction of autologous insulin-producing beta cells in the pancreas. The risk of developing T1D is determined by genetic, epigenetic and environmental factors. In the past few decades there has been a continuous rise in the incidence of T1D, which cannot be explained by genetic factors alone. Changes in our lifestyle that include diet, hygiene, and antibiotic usage have already been suggested to be causal factors for this rising T1D incidence. Only recently have microbiota, which are affected by all these factors, been recognized as key environmental factors affecting T1D development. In this review we will summarize current knowledge on the impact of gut microbiota on T1D development and give an outlook on the potential to design new microbiota-based therapies in the prevention and treatment of T1D.

KEYWORDS:

Gut microbiota; Gut permeability; Th17 cells; Treg; Type 1 Diabetes

PMID:
26051037
PMCID:
PMC4761565
DOI:
10.1016/j.clim.2015.05.013
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center